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Palatal sclerotherapy for the treatment of intermittent dorsal displacement 
of the soft palate in 51 standardbred racehorses
Daniel Jean, Valerie Picandet, Christophe Céleste, Susana Macieira, Carla Cesarini, Sophie Morisset, 
Yves Rossier, Marcel Marcoux
Abstract — This retrospective study evaluated the efficacy and side effects of palatal sclerotherapy in standardbred 
racehorses suspected to have intermittent dorsal displacement of the soft palate (IDDSP). Fifty-one horses were 
treated with multiple endoscopically guided injections of 3% sodium tetradecyl sulfate in the soft palate. Two 
groups were identified: those that had respiratory noises during exercise (n = 27) and those that did not (n = 24). 
Treatment was well-tolerated. Furthermore, horses significantly reduced their racing times for the last 400 m 
compared with their times before treatment and even when their times were compared to the mean times for horses 
in the same race. In conclusion, palatal sclerotherapy appears to be a suitable alternative therapeutic option for 
horses suspected to have IDDSP.
Résumé — Thérapie sclérosante palatale pour le traitement du déplacement dorsal intermittent du palais 
mou chez 51 chevaux de course Standardbred. Cette étude rétrospective a évalué l’efficacité et les effets secondaires 
de la thérapie sclérosante palatale chez les chevaux de course Standardbred soupçonnés d’avoir un déplacement 
dorsal intermittent du palais mou (IDDSP). Cinquante et un chevaux ont été traités avec des injections multiples 
guidées par endoscopie de 3 % de tétradécyl sulfate sodique dans le palais mou. Deux groupes ont été identifiés : 
ceux qui avaient des bruits respiratoires durant l’exercice (n = 27) et ceux qui n’en avaient pas (n = 24). Le traitement 
a été bien toléré. De plus, les chevaux ont significativement réduit leur temps de course pour les derniers 400 mètres 
comparativement à leurs temps avant le traitement et même à leur temps comparativement aux temps moyens des 
chevaux de la même course. En conclusion, la thérapie sclérosante palatale semble être une méthode de 
remplacement appropriée pour les chevaux soupçonnés d’avoir IDDSP.
(Traduit par Isabelle Vallières)
Can Vet J 2011;52:1203–1208
Introduction
I n horses, intermittent dorsal displacement of the soft palate (IDDSP) is the most common cause of exercise intolerance 
(1–4). The IDDSP obstructs the upper airways, mostly during 
the expiratory phase (5–6) and is usually associated with clini-
cal signs of poor performances and respiratory noises during 
exercise (7–8). Approximately 10% to 20% of horses diagnosed 
on the treadmill for DDSP did not make a noise and were 
referred to as silent displacers (3–7). We were interested in 
verifying the response to the treatment of this specific group. 
The pathophysiology of IDDSP seems to be complex and some 
authors have suggested that flaccidity of the soft palate due to 
neuromuscular disorders could play a role in its displacement 
during exercise (9–11). Based on these observations, one of the 
goals of treatment could be to increase the rigidity of the soft 
palate (12–14). Several therapies have been reported, including 
thermal palatoplasty with laser (15–17) and cautery (18–20).
In humans, soft palate flacidity is related to the snoring 
syndrome and contributes to obstructive sleep apnea. A recent 
treatment for these conditions consists of a soft palate stiffen-
ing procedure called “injection snoreplasty” or “palatal sclero-
therapy.” This technique involves injecting a sclerosing agent 
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(sodium tetradecyl sulfate) in the submucosal layer of the soft 
palate to induce fibrosis. It has been effective in stiffening 
the soft palate in a canine model (21) and showed promising 
results in human patients affected by snoring and sleep apnea 
(22–23). A similar approach, injecting poly-L-lactic acid into 
the soft palate, has been described in horses (24). Recently, an 
experimental study performed on horses but using lower dosages 
of sodium tetradecyl sulfate failed to detect long-term fibrosis 
in the soft palate (25).
A recent preliminary study involving young standardbred 
horses showing typical clinical signs of IDDSP demonstrated 
that palatal sclerotherapy was a safe, repeatable, inexpensive, 
and efficient procedure in the treatment of intermittent dorsal 
displacement of the soft palate (26). This retrospective study 
was designed to: 1) evaluate the efficacy of injecting a sclerotic 
agent into the soft palate of mature standardbred racehorses 
showing typical clinical signs of IDDSP with or without respira-
tory noises during exercise, 2) record the type and frequency of 
complications associated with palatal sclerotherapy in mature 
standardbred racehorses.
Materials and methods
All experimental procedures were performed in accordance with 
the guidelines of the Canadian Council for Animal Care and 
were approved by the Animal Care Committee of the Faculty of 
Veterinary Medicine of the University of Montreal.
Case selection
Horses included in this study were standardbred racehorses (2 to 
10 years old, mean: 4.6 6 2.3 y) presented to the Veterinary 
Teaching Hospital of the University of Montreal between 
January 2003 and September 2004 with a history of sud-
den unexplained exercise intolerance during the last 400 m 
of their last 2 races related or not related to abnormal upper 
respiratory sounds. Definitive inclusion of cases in the study 
further depended on clinical examination, endoscopy performed 
immediately after the race and/or at rest, and exclusion of other 
known common causes (including significant lameness) of 
exercise intolerance. Horses were separated into 2 groups based 
on whether or not abnormal respiratory noises (sudden loud 
gurgling or snoring sounds) were heard during exercise and if 
these noises were associated with a sudden speed reduction in 
the last 400 m of the race. Horses were grouped as Group A, in 
which noises were heard (n = 27) or Group B, in which noises 
were not heard (n = 24).
A physical examination of each horse including a lame-
ness examination, bronchoalveolar lavage, and post-exercise 
CK-AST (creatine kinase-aspartate aminotransferase) measure-
ment was done. Examinations also included a resting upper 
airway video-endoscopy (GIF type 100-1 meter; 9.8 mm in 
diameter, Olympus, Tokyo, Japan) with a 30 s nasal obstruction 
test when a positive endoscopic diagnosis of DDSP was made 
for horses in which the caudal portion of the soft palate dorsal 
was displaced over the epiglottis. The soft palate was subjectively 
evaluated to determine flaccidity. Lymphoid hyperplasia (phar-
yngitis) was diagnosed when there was a pronounced hyperplasia 
of the lymphonodular follicles within the pharyngeal mucosa 
and single or multiple lymphonodular masses may be within, 
or protuding from, the pharyngeal mucosa. The pharyngitis was 
graded from 1 (slight and localized) to 4 (severe and diffuse) in 
accordance with Raker’s classification (27) (Table 1).
A diagnosis of recurrent laryngeal neuropathy (RLN) was 
confirmed by identification of failure of the arytenoid cartilage 
to abduct normally during forced inspiration. The RLN was 
graded from I to IV, with IV being the most severe. Horses that 
had synchronous, complete abduction and adduction of the 
laryngeal cartilages were designated grade I. Grade II RLN was 
characterized by asynchronous movements of the arytenoids dur-
ing any phase of respiration. Grade III horses had asynchronous 
movement of the arytenoids at rest and full abduction was not 
inducible. Grade IV horses had marked asymmetry of the ary-
tenoids with no movement of one of the arytenoids during any 
phase of respiration (28). Tracheal secretion scores were defined 
as following: 0 (none), 1 (little), 2 (moderate), 3 (marked), 
4 (large) and 5 (extreme) (29).
Bronchoalveolar lavage (BAL)
Bronchoalveolar lavages were done using standard laboratory 
procedures (30). Horses were sedated with xylazine (Rompun; 
Bayer Corporation, Etobicoke, Ontario), 0.4 to 0.5 mg/kg 
bodyweight (BW), IV, followed 10 min later by butorphanol 
(Torbugesic; Fort Dodge Animal Health, Fort Dodge, Iowa, 
USA), 20 to 30 mg/kg BW, IV. A fiber-optic flexible endo-
scope (250 cm long, 10.5 mm diameter; SIF-0140; Olympus, 
Tokyo, Japan) was passed through the nasal passage until it was 
wedged in the distal right bronchus. Two 250-mL boluses of 
sterile isotonic saline solution (NaCl 0.9%; Baxter Corporation, 
Mississauga, Ontario) at 37°C were instilled and aspirated. Total 
nucleated cell counts were determined using a hemocytometer. 
Differential counts were obtained from 400 cells, under oil-
immersion microscopy; epithelial cells were excluded from the 
differential cell count.
Table 1. Description of different grades of pharyngeal lymphoid 
hyperplasia in horses as described by Raker and Boles (27)
Grades Description
I There are few small white lymphoid follicles scattered over 
the dorsal pharyngeal wall. These appear to be inactive and 
shrunken. This appearance of the pharyngeal mucosa was 
considered normal for the young horses.
II Many small white lymphoid follicles lying close together 
on the dorsal and lateral pharyngeal walls, not unlike the 
appearance of coarse sandpaper. Laterally they extend to or 
slightly below the pharyngeal openings to the guttural pouch.
III Presence of pink and white lymphoid follicles which lie very 
close together, covering the entire dorsal and lateral 
pharyngeal walls. They extend below the openings to the 
guttural pouches and often involve the dorsal surface of 
the soft palate.
IV The follicles appear large and edematous and cover an 
extensive area as in grade III. They may extend into the 
guttural pouches and are frequent accompanied by numerous 
polyps arising from the mucosa of the pharyngeal 
diverticulum or the dorsal and lateral pharyngeal walls.








The procedure was as described in a previous study (26). A semi-
rigid plastic tube (#076X038-pc; Putnam Plastics Corporation, 
Dayville, Connecticut, USA), to the distal end of which the 
metal part of a 20-gauge needle had been snugly fitted and 
glued in place (Cyanoacrylate adhesive; Permabond, Somerset, 
New Jersey, USA), was passed through the instrument channel 
of a 10-mm videoendoscope (GIF type 100-1 meter; Olympus). 
The channel lining was protected from puncture by a Teflon 
sleeve (Teflon sheath-HX-20L-1, model maj-251; Olympus) 
inserted into the instrument channel so that 1 cm protruded 
from the end of the endoscope. The channel was also protected 
by covering the end of the needle with a 1-cm long accessory 
piece of the tube during passage through the channel. When the 
tube was completely inserted in the channel, the accessory piece 
covering the needle was removed and the tube was retracted so 
that the needle would be located within the protective sleeve at 
about 1 cm from the end of the videoendoscope.
Injection of the soft palate with the sclerosing agent was 
performed with the horses restrained in stocks by a nose-twitch 
and sedated with xylazine (Rompun; Bayer, Etobicoke, Ontario), 
0.5 mg/kg BW, IV, and butorphanol (Torbugesic; Fort Dodge 
Animal Health), 0.025 mg/kg BW, IV.
The videoendoscope was inserted into the nostril and 
advanced into the nasopharynx. The nasal and pharyngeal 
mucous membranes were then anesthetized with a solution of 
30 mL of saline solution and 10 mL of lidocaine (Lurocaine, 
20 mg/mL; Vétoquinol N-A, Lavaltrie, Quebec) delivered 
through the accessory channel of the videoendoscope. Before 
injection, and to facilitate visualization of the distal border of 
the soft palate, dorsal displacement of the free distal margin of 
the soft palate was obtained with a blunt-end hook inserted 
through the contralateral nostril. The injections were aimed 
at the submucosal level of the distal 2/3 of the soft palate and 
each horse received 8 to 10 injections of 1 mL of 3% sodium 
tetradecyl sulfate (Tromboject; Omega Laboratory, Montreal, 
Québec) depending on its body weight (1 injection/50 kg BW). 
Phenylbutazone (generic), 4.4 mg/kg BW, IV, was administered 
at the end of the procedure; subsequently, the horses received 
phenylbutazone (2.2 mg/kg BW, PO, q12h) for 2 d. The horses 
were discharged immediately after treatment with specific 
instructions to be stall rested or hand walked for 5 d and to 
do slow jogging exercise for the 15 subsequent days. A post-
sclerotherapy endoscopy was performed to evaluate the upper 
respiratory airway in cases with complications (cough, dyspnea) 
after treatment.
After this period of 15 d, upper respiratory endoscopy was 
performed in all horses; if the soft palate still seemed more flac-
cid than normal on visual evaluation the procedure was repeated.
Post-treatment performance evaluations
Objective evaluations of performances were assessed by review-
ing the racing records obtained from the official Quebec racing 
authorities and by comparing the times of the horse recorded 
during the last 1/4 mile (400 m) for each horse in the last 
2 races (mean times). Evaluations were done 1) before and 
after treatment, and 2) between the treated horse and the rest 
of the horses in the same races (mean times) before and after 
treatment.
Statistical analysis
A repeated-measures linear model was used to compare average 
race times during the last 1/4 mile (400 m) for each horse in the 
last 2 races before treatment and the first 2 races after treatment. 
In addition, the differences in race times between each horse 
and the race field (delta) were calculated for the same races. 
A repeated-measures linear model was used to compare averaged 
delta during the last 1/4 miles (400 m) before and after treat-
ment. The following factors were included in the 2 models: group 
(with and without noises), the interaction between time and 
group, chronicity of the problem, the occurrence of pharyngitis, 
exercise-induced pulmonary hemorrhage (EIPH), airways inflam-
matory disease (AID), RLN, tracheal secretion, exercise-induced 
myopathy and the presence of IDDSP during endoscopy. A value 
of P , 0.05 was considered statistically significant.
Results
Clinical findings
Fifty-one horses (13 males, 17 geldings, and 21 females) met 
the inclusion criteria. One horse was excluded because of lame-
ness. Results of physical examination of 43 of the 51 horses 
were unremarkable, 5 horses showed minor thrombophlebitis, 
2 horses had tracheal wheezes, and 1 showed a scar from a previ-
ous tracheal trauma.
Endoscopic and procedure findings
According to Raker’s classification (27) and based on endoscopic 
findings, horses had grade 1 (n = 2), grade 2 (n = 15), grade 3 
(n = 16) and grade 4 (n = 4) lymphoid hyperplasia (pharyngitis); 
aryepiglottic folds vibration (n = 3); partial pharyngeal roof 
collapse (n = 1); grade 1 (n = 46) and grade 2 (n = 3) RLN; 
grade 0 (n = 49) and grade 1 tracheal secretion (n = 8); and in 
1 case a fibrous callus involving a fracture of 3 tracheal rings 
which induced a minimal reduction of the tracheal diameter 
(, 10%). Thirteen of the 51 horses showed IDDSP based on 
the nasal occlusion performed on endoscopic examination and 
3 horses had ulceration of the free margin of the soft palate 
(including 2 horses with both IDDSP and ulceration and 1 
with only soft palate ulceration). Except for the DDSP, none of 
the abnormalities were considered sufficient to logically explain 
the sudden and important race exercise intolerance in all horses 
and the sudden and violent appearance of the “snoring-like” 
respiratory noises which always occurred concomitantly with 
the appearance of intolerance in the specific noise category. 
Cytology on BAL fluid performed on 48 horses revealed signs 
of pulmonary hemorrhage in 35 horses and cytological evidence 
of small inflammatory airway (neutrophils . 5% and/or mast 
cells . 2%) in 18 horses. Thirteen horses had abnormal post-
exercise elevations of AST [. 384 U/L; reference interval (RI): 
409 to 3080 U/L; n = 10] and/or CK (. 444 U/L; RI: 518 to 
2090 U/L; n = 7) on plasma samples, suggesting a subclinical 
exercise-induced myopathy.
Following the injection procedure only 8 horses developed 
minor side effects of which only 4 were detected endoscopically 







(significant soft palate inflammation). One horse had temporary 
mucosal bleeding (1 to 2 h) just after the procedure, 2 horses 
had occasional coughing for 1 wk related to the palate inflam-
mation after injection. The cough was mostly associated with 
eating. One of the horses that coughed had a moderate fever 
(2 d duration) of unknown origin which resolved without treat-
ment. Another horse developed pleuropneumonia 2 wk after 
treatment but no relationship to the procedure could be found.
Post-treatment performance evaluations
Objective evaluations of individual racing performances were 
available for all horses from 7 to 13 mo after treatment (Tables 2 
and 3). The linear model of repeated measures indicated a 
significant beneficial effect (P = 0.02) of the treatment on the 
racing times of the last 1/4 mile (400 m) of the treated horses 
compared with their individual pre-treatment times [improve-
ment of 31/48 horses (65%)], and compared with the mean time 
of the rest of the horses in the field (P = 0.03) [improvement 
of 28/48 horses (58%)], and this effect was the same for both 
groups (with and without noises) (Table 3). Interestingly, the 
times of racing (P = 0.009) and the last quarter miles (400 m) 
(P = 0.03) were significantly higher for horses with pulmonary 
hemorrhage compared to horses without.
Discussion
This retrospective study evaluated the efficacy and the side 
effects of palatal sclerotherapy as a treatment of IDDSP in stan-
dardbred racehorses showing exercise intolerance with or with-
out abnormal respiratory noises. The most significant finding 
of this study is the greatly reduced times to run the last 400 m 
of races compared with times before treatment [31/48 horses 
(65%)], even when times were compared with the mean times 
of other horses in the field, which helps to partially dampen the 
effect of different racing conditions on the results. This 65% 
improvement of horses with suspected IDDSP is in the range of 
other previous treatments proposed to control IDDSP in race-
horses: 58% to 70% for sternothyrohyoideus myectomy (31,32), 
60% for staphylectomy (33), 53% for epiglottic augmentation 
(34), 63% to 92% for laser thermoplasty (15,35), 60% to 78% 
for various composite surgeries (36,37), and more recently, 80% 
to 82% for laryngeal tie-forward (38). Based on these results, 
palatal sclerotherapy with 3% sodium tetradecyl sulfate repre-
sents a non-invasive, repeatable, safe alternative procedure for 
the treatment of IDDSP in standardbred horses; it requires no 
sophisticated equipment and is easy to perform.
The efficacy of this procedure was probably due to the scle-
rosing effect of the drug, which, should, as in humans (23), 
increase the rigidity of the soft palate and thus help to prevent 
its displacement during exercise. Contrary to previous findings 
in small animals and humans, an experimental study using 
normal soft palates of horses failed to detect any fibrosis or 
stiffening after sclerotherapy (25). However the dosage used in 
the Munoz study (25) was lower than the dose used herein. It 
would seem logical that the tissue reaction is dose-dependent. 
It is also possible that abnormal tissues might react differently 
than normal tissues. Both factors (lower dose and normal tissues 
in the context of Munoz study) could explain the different data 
from the 2 studies. Additionally, the lack of a definitive diagno-
sis of IDDSP in horses might have had an effect on our results.
Studies, including this one, assessing the success of treatment 
of horses with IDDSP have been plagued by at least 2 factors: 
1) in the absence of a precise and reliable method of diagnosis 
there is doubt concerning the selection of cases; and, 2) there 
is related doubt surrounding the assessment of resolution of 
IDDSP. Most clinicians agree, however, that IDDSP is the 
most probable pathology, if not the only one, that occurs on 
an important clinical scale and is related to sudden and violent 
respiratory noises that occur concomitantly with the appearance 
of important exercise intolerance in the last 400 m of a race.
The gold standard for establishing an IDDSP diagnosis is the 
observation of a soft palate positioned dorsally to the epiglottic 
cartilage for multiple breaths, that is for . 8 s (5) during high-
speed treadmill video-endoscopy or with dynamic overground 
endoscopy. Therefore, the power of our study would have been 
stronger with treadmill endoscopic examination. However, this 
was not acceptable to most owners for financial reasons and 
Table 2. Correlation between the presence of lymphoid 
hyperplasia, airway inflammatory disease (AID), exercise-induced 
pulmonary haemorrhage (EIPH), and exercise induced myopathy, 
with racing time, last 1/4 race time (L 1/4 RT) and the difference 
between last 1/4 race times versus field time (D 1/4 RC versus FT) 
in horses suspected of IDDSP before and after palatal 
sclerotherapy. Racing times were available for 48/51 horses
   D 1/4 RC 
 Race time L 1/4 RT versus FT
Lymphoid pharyngeal hyperplasia P = 0.98 P = 0.93 P = 0.84
Inflammatory airway disease P = 0.40 P = 0.78 P = 0.38
Exercise-induced pulmonary  P = 0.76 P = 0.96 P = 0.72 
 hemorrhage
Exercise-induced myopathy P = 0.99 P = 0.71 P = 0.89
Table 3. Raw data of the race times (seconds), the last 1/4 race 
time, and the difference between last 1/4 race time and field time 
in horses without noise (Group A) and with noise (Group B) for the 
periods pre- and post-palatal sclerotherapy
 Mean 6 SE (Time in s)
Race time
 Group A pre-treatment 121.03 6 0.8
 Group A post-treatment 121.19 6 0.8
 Group B pre-treatment 121.72 6 0.7
 Group B post-treatment 121.50 6 0.7
Last 1/4 race time
 Group A pre-treatment 31.2 6 0.4a
 Group A post-treatment 30.4 6 0.4a
 Group B pre-treatment 31.2 6 0.4a
 Group B post-treatment 30.3 6 0.4a
Difference between last 1/4 race time  
versus field time
 Group A pre-treatment 21.31 6 0.3b
 Group A post-treatment 20.82 6 0.3b
 Group B pre-treatment 21.11 6 0.22b
 Group B post-treatment 20.56 6 0.22b
a Significant difference of the last 1/4 race time before and after palatal sclerotherapy 
with P , 0.05. 
b Significant difference of the difference between last 1/4 race time and field time 
before and after palatal sclerotherapy with P , 0.05.







the guarded prognosis of these horses as future race animals. In 
this study, a treadmill evaluation could possibly have identified 
horses with other causes of dynamic obstruction or displace-
ment. The selection of our cases was performed with referring 
veterinarians to ensure that the clinical signs of the exercise 
intolerance were suggestive of IDDSP. Barakzai et al (39) 
reported that the presence of spontaneous DDSP during resting 
endoscopic examination as an inclusion criterion for investigat-
ing efficacy of treatments for DDSP is likely to result in a low 
proportion of horses with false positive diagnoses. However, 
Lane et al (40) reported that a palatal malfunction misdiagnosis 
rate of 35% would be suspected in thoroughbred racehorses 
and should be considered in the case selection process.
The second point is the related doubt surrounding the assess-
ment of resolution of IDDSP. In our study, for the objective 
evaluation of performance improvement, we used the following 
measurements: 1) the difference in racing times between the last 
1/4 mile (400 m) of the 2 races before and the 2 races after the 
treatment, and 2) the time difference between the last 1/4 mile 
of each treated horses and the rest of the horse field for the 
2 races before and after treatment. This objective evaluation 
considered 2 important factors during a race: the comparison 
of the horse with itself and with other horses during the same 
race. We feel that this objective evaluation obtained in the last 
400 m corresponds to the usual clinical picture of IDDSP in 
standardbred racing horses in which horses are known to com-
plete the last part of their races with great difficulty. However, 
we cannot exclude that other positive factors (such as rest) had 
an effect on the 2 racings after treatment.
The results obtained in this study are as good as those 
obtained with most previously reported medical or surgical treat-
ments attempted on mature racehorses. However, without the 
use of endoscopy, it is impossible to prove that IDDSP had truly 
resolved in any case. The assumption that the pathophysiology 
of IDDSP seems to be multifactorial probably accounts for 
some of the variation in success rates reported in the literature 
and in our study.
Interestingly, groups of horses (with and without abnormal 
respiratory noises) responded almost identically to treatment. 
Silent displacers have been reported in several papers (7,39,40). 
The results herein seem to support this fact in a racing envi-
ronment and that a silent form of IDDSP is a real entity in 
racehorses.
In conclusion, sclerotherapy of the soft palate in suspicious 
cases of IDDSP in standardbred horses is an interesting medical 
option which requires only a short recovery time. This treat-
ment could be considered as a first line therapeutic approach 
in IDDSP in a racehorse. Compared with other techniques, 
palatal sclerotherapy does not require general anesthesia and 
sophisticated equipment, is relatively easy to perform, is not 
costly, and does not cause significant side effects. Furthermore, 
the treatment can be easily repeated if clinical results are not 
satisfactory or permanent.
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